Jiajia Yuan

机构：Peking University, Peking University Cancer Hospital

发表论文 1 篇

代表论文

• Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial (2026 · British Journal of Cancer)